Epithelial Ovarian Cancer Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

(Albany, US) DelveInsight has launched a new report on Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030.

DelveInsight's " Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Epithelial Ovarian Cancer, historical and forecasted epidemiology as well as the Epithelial Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of Epithelial Ovarian Cancer Facts:

·         The rate of new cases of ovarian cancer was 11.2 per 100,000 women per year. The death rate was 6.7 per 100,000 women per year.

·         Epithelial ovarian carcinomas (EOC) account for ~90% of all ovarian malignancies.

·         In 2020 more than 300 000 new cases of EOC are expected worldwide, with more than 190 000 deaths.

·         Ovarian cancer is a disease that affects women. This cancer mainly develops in older women.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market

View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market

Scope of Epithelial Ovarian Cancer Report:

  • The report covers the descriptive overview of Epithelial Ovarian Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Epithelial Ovarian Cancer epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Epithelial Ovarian Cancer are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Epithelial Ovarian Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Epithelial Ovarian Cancer market

Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market

View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market

Ovarian cancer is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. It is one of the most common gynecologic cancers, and one of the leading causes of cancer-associated female mortality in the world. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.

The ovaries are mainly made up of 3 kinds of cells. Each type of cell can develop into a different type of tumor:

 Epithelial tumors start from the cells that cover the outer surface of the ovary. Most ovarian tumors are epithelial cell tumors.

Germ cell tumors start from the cells that produce the eggs (ova).

Stromal tumors start from structural tissue cells that hold the ovary together and produce the female hormones estrogen and progesterone.

Epithelial ovarian tumors develop from the cells that cover the outer surface of the ovary. Most epithelial ovarian tumors are benign. There are several types of benign epithelial tumors, including serous adenomas, mucinous adenomas, and Brenner tumors. Cancerous epithelial tumors are carcinomas - meaning they begin in the tissue that lines the ovaries.

There are some ovarian epithelial tumors whose appearance under the microscope does not clearly identify them as cancerous and they are called borderline tumors or tumors of low malignant potential (LMP tumors).

Epithelial cancer of the ovary is thought to derive from malignant transformation of the epithelium of the ovarian surface, peritoneum, or fallopian tube. The exact molecular transformation events causing EOC are not known. Studies have shown that epigenetic phenomenon may also play a role. Mutations of the oncogenes HER2, C-myc, K-ras, Akt, and the tumor suppressor gene p53 have been observed.

The clinical presentation of EOC can either be acute or subacute. Acute cases present with conditions such as pleural effusion, small bowel obstruction and venous thromboembolism.

Subacute cases may present with non specific symptoms such as abdominal fullness, bloating, an adnexal mass, vague pelvic or abdominal pain and gastrointestinal symptoms.

During the last decade it has become apparent that EOC encompasses 5 distinct diseases, with different presentations (age of development, distribution of disease), response to chemotherapy, prognosis, molecular features, and site of origin. While these carcinomas share a common site of tumor growth in the ovary, they represent diverse diseases entities. This has driven the move towards more histotype specific management strategies.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market

View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market

Some of Epithelial Ovarian Cancer Companies:

·         Immunogen

·         Celsion Corporation

·         OncoQuest

·         Roche

·         Precigen

·         Ellipses Pharma

·         And Many Others

Epithelial Ovarian Cancer Drugs Covered:

·         Mirvetuximab

·         GEN-1

·         Oregovomab

·         Tecentriq

·         PRGN-3005 UltraCAR-T

·         EP0057

·         And Many Others

Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market

View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market

Table of Contents:

1. Key Insights

2. Executive Summary of Epithelial Ovarian Cancer

3. Competitive Intelligence Analysis for Epithelial Ovarian Cancer

4. Epithelial Ovarian Cancer: Market Overview at a Glance

5. Epithelial Ovarian Cancer: Disease Background and Overview

6. Patient Journey

7. Epithelial Ovarian Cancer Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Epithelial Ovarian Cancer Treatment

11. Marketed Products

12. Emerging Therapies

13. Epithelial Ovarian Cancer: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Epithelial Ovarian Cancer

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Related Reports:

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more